Advertisement

Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL
Posted: 01/17/2022 | By: Liz Janetschek Pasini

Question 1 of 5

What are the response rates for patients with relapsed or refractory DLBCL treated with currently available therapies?

Choose 1

A
Overall response rate = around 35%, complete response rate = around 12%
B
Overall response rate = around 9%, complete response rate = around 3%
C
Overall response rate = around 26%, complete response rate = around 7%
D
Overall response rate = around 14%, complete response rate = around 5%

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage